Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fabrizi

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studiesF Fabrizi, P Martin, V Dixit, et al.
The International Journal of Artificial Organs|July 9, 2008
Hepatitis B virus infection in the dialysis population: current perspectivesF Fabrizi, A Marzano, P Messa, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 18, 2004
[Hepatitis C virus and renal transplantation]F Fabrizi, P Martin, G Lunghi, et al.
Journal of Viral Hepatitis|May 1, 2008
Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trialsF Fabrizi, S V Ganeshan, G Lunghi, et al.
Nephron|January 1, 1996
Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid functionF Fabrizi, G Bacchini, S Di Filippo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver diseaseF Fabrizi, D Marcelli, G Bacchini, et al.
Nephron|January 1, 1993
Conflicting results of hepatitis C virus serological tests in haemodialysis patientsF Fabrizi, L Raffaele, I Guarnori, et al.
Alimentary Pharmacology & Therapeutics|April 2, 2005
De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assayF Fabrizi, A F de Vecchi, G Como, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2005
Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantationF Fabrizi, P Lampertico, G Lunghi, et al.
The International Journal of Artificial Organs|April 10, 2007
Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trialsF Fabrizi, A Bruchfeld, S Mangano, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studiesF Fabrizi, P Martin, V Dixit, et al.
The International Journal of Artificial Organs|July 9, 2008
Hepatitis B virus infection in the dialysis population: current perspectivesF Fabrizi, A Marzano, P Messa, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 18, 2004
[Hepatitis C virus and renal transplantation]F Fabrizi, P Martin, G Lunghi, et al.
Journal of Viral Hepatitis|May 1, 2008
Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trialsF Fabrizi, S V Ganeshan, G Lunghi, et al.
Nephron|January 1, 1996
Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid functionF Fabrizi, G Bacchini, S Di Filippo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver diseaseF Fabrizi, D Marcelli, G Bacchini, et al.
Nephron|January 1, 1993
Conflicting results of hepatitis C virus serological tests in haemodialysis patientsF Fabrizi, L Raffaele, I Guarnori, et al.
Alimentary Pharmacology & Therapeutics|April 2, 2005
De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assayF Fabrizi, A F de Vecchi, G Como, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2005
Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantationF Fabrizi, P Lampertico, G Lunghi, et al.
The International Journal of Artificial Organs|April 10, 2007
Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trialsF Fabrizi, A Bruchfeld, S Mangano, et al.
Pageof 15